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Abstract: A series of fluorogenic enzymatic substrates that incorporate a self-immolative spacer 
were synthesised for the purpose of identifying L-alanylaminopeptidase activity in microorganisms in 
agar media. These substrates resulted in the generation of fluorescent microorganism colonies with 
Gram-negative microorganisms.  
Keywords: fluorogenic enzyme substrates, L-alanylaminopeptidase detection, microorganisms. 
1. Introduction 
Molecules that contain self-immolative spacers have found widespread applications in areas such as 
drug delivery, prodrug systems, chemical sensors and enzyme sensors.1 In one aspect of self-
immolative spacer design, fluorescent substrates of general structure 1 have been constructed 
around a para-aminobenzyl alcohol (PABA) core for the purpose of enabling the detection of 
protease enzyme activity as outlined in Scheme 1. This system is designed so that the presence of a 
protease enzyme results in the release of a fluorescent phenolic derivative 4. Thus, the weakly 
fluorescent substrates 1 are hydrolytically cleaved by an appropriate enzyme producing the O-
arylated-4-aminobenzyl alcohol intermediate 2 which subsequently undergoes fragmentation with 
concomitant liberation of the imine 3 and the fluorescent phenolic derivative 4. Renard, Romieu and 
co-workers described the preparation of two fluorescent substrates based on the general structure 1; 
a sensor 5 for the detection of penicillin G acylase2,3 and a probe 6 for determining Caspase-3 activity 
(Figure 1).2 Structurally related chemiluminescent substrates for detecting  penicillin G acylase and 
Caspase-3 activities have also been described.4 A fluorogenic assay based on structure 7 for 
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monitoring the activity of the autophagy-initiating enzyme ATG4B has recently been reported 
(Figure 1).5  
 
 
Scheme 1. Fluorogenic self-immolative spacers for protease detection. 
 
 
Figure 1. PABA-based fluorogenic self-immolative spacers for protease detection. 
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Scheme 2. Fluorogenic L-alanylaminopeptidase substrates. 
The identification of specific types of enzyme activity in microorganisms has proved tremendously 
useful in diagnostic microbiology.6 Of particular relevance to this paper is the detection of L-
alanylaminopeptidase activity which has enabled the differentiation between Gram-positive and 
Gram-negative microorganisms.7,8 This enzyme is widely distributed in Gram-negative 
microorganisms whereas, in contrast, it is generally absent or less abundant  in most Gram-positive 
microorganisms.  Fluorogenic substrates that have been used for the detection of L-
alanylaminopeptidase activity include the commercially available coumarin derivative 8 which 
liberates the highly fluorescent 7-amino-4-methylcoumarin 9 in the presence of an L-
alanylaminopeptidase enzyme (Scheme 2). We have previously described the synthesis and 
evaluation of a series of fluorogenic substrates 10 (X = S, O) that produced the corresponding 
fluorescent 2-(2-aminophenyl)benzoxazole 11 (X = O) and 2-(2-aminophenyl)benzothiazoles 11 (X = S) 
in the presence of L-alanylaminopeptidase.9  Fluorogenic L-alanylaminopeptidase substrates derived 
from 2-(4-aminophenyl)benzothiazoles were also prepared and evaluated.10                     
2. Synthesis of substrates 
The substrates depicted in Scheme 2 all liberate fluorescent heterocyclic amine derivatives. In view 
of the availability and structural diversity of fluorescent phenols, we wished to develop substrates 
that would enable the detection of L-alanylaminopeptidase activity in microorganisms such that a 
fluorescent phenolic derivative is produced. A potential benefit of these proposed substrates would 
be that fluorogenic phenols with specific properties, e.g.  tailored excitation/emission wavelengths, 
could be selected from an extensive pool of known molecules hence  extending  the availability of 
fluorophores that might be incorporated into aminopeptidase substrates. Thus, in this paper we 
describe the synthesis and evaluation of a series of novel self-immolative spacer substrates 18 (Table 
1) for the purpose of detecting L-alanylaminopeptidase activity in microorganisms.  
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The synthetic route chosen for the preparation of the substrates 18 is shown in Scheme 3. 
Commercially available 4-aminobenzyl alcohol 13 was found to be relatively unstable to storage and 
hence it was prepared immediately before use by reduction of the readily available and inexpensive 
4-nitrobenzyl alcohol 12. A mixed anhydride condensation of amine 13 with Boc-protected L-alanine 
furnished compound 14 which was reacted with methanesulphonyl chloride giving the benzylic 
chloride 15 directly, presumably via displacement of the mesylate group in the initially formed 
mesylate derivative by chloride. Compound 15 was then reacted with an appropriate heterocyclic 
phenol  16 under basic conditions affording the Boc-protected derivatives 17a-e. Treatment of these 
compounds with hydrogen chloride produced the required substrates 18a-e respectively as their 
hydrochloride salts.  
 
 
Scheme 3. Synthesis of substrates 18. Reagents and conditions: (i) Cu(II)(acac)2, NaBH4, EtOH, rt; (ii) 
Boc-L-alanine, iBuOCOCl, N-methylmorpholine, THF, -5 oC, 2 h then rt 20 h; (iii) MeSO2Cl, Et3N, CH2Cl2, 
0 oC, 2 h then rt 18 h; (iv) Cs2CO3, DMF, 80-90 oC, 3-12 h; (v) EtOAc/HCl, rt, 1-2 h. 
 
ArOH 16 Boc-protected amines 17 and substrates 18  
 
 
 
 
        
                       
                          16a 
 
 
 
                       17a R = Boc      91% 
                       18a R = H. HCl  90% 
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                          16ba 
 
 
 
                       17b R = Boc      49% 
                       18b R = H. HCl  95% 
 
 
 
 
          
 
                         16c 
 
 
       
 
                       17c R = Boc      26% 
                       18c R = H. HCl  83% 
 
 
 
         
                     
                       16d 
 
 
 
                       17d R = Boc      84% 
                       18d R = H. HCl  97% 
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                       16e 
 
                       17e R = Boc      67% 
                       18e R = H. HCl  59% 
 
a 3-Hydroxyflavone similarly gave a Boc-protected amine. However, attempted removal of the Boc-
group resulted in fragmentation and formation of 3-hydroxyflavone. 
Table 1. Structures and yields of self-immolative spacer substrates 18 and their Boc-protected 
precursors 17 
Based upon previous studies, di-L-alanyl aminopeptidase substrates were found to be less inhibitory 
to Gram-positive bacteria.7 Thus, the substrate 22 was also prepared as part of this study in order to 
assess its scope of activity (Scheme 4).  Removal of the Boc-group in compound 15 under acidic 
conditions gave compound 19 which was then subjected to a mixed anhydride coupling reaction 
with Boc-L-alanine affording the protected di-L-alanyl derivative 20. The reaction of compound 20 
with 6-(1,3-benzothiazol-2-yl)naphthalene-2-ol 16e under basic conditions yielded compound 21 
from which the required substrate 22 was obtained by treatment with hydrogen chloride (Scheme 4). 
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Scheme 4. Synthesis of the substrate 22. Reagents and conditions: (i) EtOAc/HCl, rt, 1-2 h; (ii) Boc-L-
alanine, iBuOCOCl, N-methylmorpholine, DMF , -5 oC, 2 h then rt 20 h; (iii) 16e, Cs2CO3, DMF, 80-90 
oC, 12 h.  
3. Evaluation of substrates 
Each substrate was evaluated in Columbia agar media (37 oC in air for 18 hours) on a single plate 
against 20 clinically important microorganisms, including 10 Gram-negative bacteria, 8 Gram-
positive bacteria and 2 yeasts (substrate concentration 100 mgL-1). The growth of the 
microorganisms was compared to control plates in which no substrate was present. The Gram-
negative microorganisms all grew well on the control plates whereas the Gram-positive 
microorganisms and the yeasts showed only moderate growth. Figure 2 depicts the arrangement of 
microorganisms on the agar plates and shows a representative example of an agar plate produced 
by incorporation of substrate 18e into the media. 
 
 
 
Arrangement of microorganisms on platesa Substrate 18e  
a Microorganisms are numbered in the sequence shown in the Tables. Pink spots represent Gram-
negative bacteria, blue spots represent Gram-positive bacteria and the yeast species. 
Figure 2. Representative Columbia agar plate depicting fluorescence generated by various 
microorganisms with substrate 18e when viewed under UV illumination (360 nm).   
The coumarin substrate 18a gave intense, blue fluorescent colonies with most of the Gram-negative 
bacteria and moderately intense, blue fluorescent colonies with four of the Gram-positive bacteria (S. 
pyogenes, L. monoctogenes, E. faecium and E. faecalis) and also with the yeast species, C. albicans 
(Table 2). There was some diffusion of the fluorescence from the colonies into the surrounding 
media with this substrate and this could be a potential disadvantage when investigating 
polymicrobial cultures obtained from pathological specimens because the diffusion of fluorescence 
through the agar media into surrounding colonies may not allow a clear differentiation of species 
that demonstrate enzyme activity. The 7-hydroxyflavone derived substrate 18b produced 
moderately intense, yellow fluorescent colonies with most of the Gram-negative bacteria (Table 2). 
Growth of the majority of the Gram-positive bacteria was inhibited by this substrate and hence no 
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fluorescence was observed. Growth of the yeast species, C. glabrata, was also inhibited by this 
substrate whereas C. albicans did show moderate growth but only produced very weak fluorescence. 
  18a 18b 
 Microorganism / Referencea Growthb Fluorescencec Growthb Fluorescencec 
 Gram-negative microorganisms     
1 Escherichia coli NCTC 10418  ++ ++ blue  ++  + yellow 
2 Klebsiella pneumoniae NCTC 9528  ++ ++ blue  ++  + yellow 
3 Providencia rettgeri NCTC 7475  ++ + blue  ++  + yellow 
4 Enterobacter cloacae NCTC 11936  ++ ++ blue  ++  + yellow 
5 Serratia marcescens NCTC 10211  ++ ++ blue  ++  + yellow 
6 Salmonella typhimurium NCTC 74  ++ ++ blue  ++  + yellow 
7 Pseudomonas aeruginosa NCTC 10662  ++ + blue  ++  - 
8 Yersinia enterocolitica NCTC 11176  ++ ++ blue  ++  + yellow 
9 Burkholderia cepacia NCTC 10743  ++ ++ blue  ++  + yellow 
10 Acinetobacter baumannii NCTC 12156  ++ ++ blue  ++  + yellow 
      
 Gram-positive microorganisms     
11 Streptococcus pyogenes NCTC 8306  +  + blue  -  - 
12 Staphylococcus aureus (MRSA) NCTC 11939  + -  - - 
13 Staphylococcus aureus  (MSSA) NCTC 6571  +/-  -  -  - 
14 Staphylococcus epidermidis NCTC 11047  -  -  -  - 
15 Listeria monocytogenes NCTC 11994  +  + blue  Tr.  - 
16 Enterococcus faecium NCTC 7171  +  + blue  -  - 
17 Enterococcus faecalis NCTC 775  + + blue  + - 
18 Bacillus subtilis NCTC 9372  Tr.  -  -  - 
      
 Yeasts     
19 Candida albicans ATCC 90028 +  + blue  +  Tr. yellow  
20 Candida glabrata NCPF 3943 +  - Tr.  - 
aNCTC: National Collection of Type Cultures; ATCC: American Type Culture Collection; NCPF: National 
Collection of Pathogenic Fungi. 
b ++ strong growth, + moderate growth, +/- weak growth, Tr. trace of growth. 
c ++ strong fluorescence, + moderate fluorescence, +/- weak fluorescence, Tr. trace of fluorescence. 
Table 2. Evaluation of substrates 18a and 18b.  
The substrates 18c-e all produced highly fluorescent colonies with the panel of Gram-negative 
microorganisms (Table 3). Thus, the benzothiazole derivative 18d gave intensely yellow fluorescent 
colonies with all of the Gram-negative bacteria. This substrate was inhibitory towards the Gram-
positive bacteria and no growth was apparent and hence no fluorescent colonies were produced. 
The yeast species, C. albicans, grew moderately well and produced blue-fluorescent colonies. The 
substrates 18c and 18e both gave similar results to substrate 18d, except that the colonies of Gram-
negative bacteria were associated with an intense green fluorescence (substrate 18c, data not 
shown) and a strong blue fluorescence (substrate 18e). The observed fluorescence with substrates 
18c-e was restricted to the microorganism colonies and this is an advantage over our previously 
described substrates 10 in which noticeable diffusion of the fluorophore into the surrounding media 
was apparent.9 Additionally, some diffusion of the fluorophore is also observed with the 
aminocoumarin-derived substrate 8 in agar media. In accord with expectation, the di-L-alanyl 
substrate 22 was less inhibitory towards most of the selection of Gram-positive microorganisms 
compared to the mono-L-alanyl substrate 18e and consequently blue fluorescent colonies were 
produced with growing Gram-positive microorganisms and also with both yeasts. It is interesting to 
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note that a chromogenic L-alanylaminopeptidase substrate based on a 9-(4-aminophenyl)-10-
methylacridinium core was non-inhibitory to five of a panel of ten Gram-positive microorganisms 
and did not undergo hydrolysis even when microorganism growth occurred.7 The di-L-alanyl-
analogue was even less inhibitory, allowing growth of nine of the same panel of Gram-positive 
microorganisms. This contrasts with our work described here and elsewhere,9 in which the L-alanyl 
fluorogenic substrates were often inhibitory to most Gram-positive microorganisms. This difference 
in detection profile between these two sets of fluorogenic and chromogenic substrates might be 
attributed to a variety of factors, including for example, the greater sensitivity of fluorogenic 
substrates, the higher degree of toxicity of the fluorogenic substrates to Gram-positive 
microorganisms, the degree of permeation of the substrates into the cell and structural differences 
between the substrates; the chromogenic substrates are quaternised heterocycles whereas the 
fluorogenic substrates are not. 
 
 
  18d  18e 22 
 Microorganism / 
Referencea 
Growthb Fluorescencec Growthb Fluorescencec Growthb Fluorescencec 
 Gram-negative 
microorganisms       
1 Escherichia coli 
NCTC 10418  ++  ++ yellow  ++  ++ blue  ++  ++ blue 
2 Klebsiella 
pneumoniae NCTC 
9528  ++  ++ yellow  ++  ++ blue 
 ++ 
 ++ blue 
3 Providencia 
rettgeri NCTC 
7475  ++ 
 ++ yellow 
 ++  ++ blue 
 ++ 
 ++ blue 
4 Enterobacter 
cloacae NCTC 
11936  ++ 
 ++ yellow 
 ++ ++ blue 
 ++ 
 ++ blue 
5 Serratia 
marcescens NCTC 
10211  ++ 
 ++ yellow 
 ++  ++ blue 
 ++ 
 ++ blue 
6 Salmonella 
typhimurium 
NCTC 74  ++ 
 ++ yellow 
 ++  ++ blue 
 ++ 
 ++ blue 
7 Pseudomonas 
aeruginosa NCTC 
10662  ++ 
 ++ yellow 
 ++ ++ blue 
 ++ 
 ++ blue 
8 Yersinia 
enterocolitica 
NCTC 11176  ++ 
 ++ yellow 
 ++ ++ blue 
 ++ 
++ blue 
9 Burkholderia 
cepacia NCTC 
10743  ++ 
 ++ yellow 
 ++ ++ blue 
 ++ 
 ++ blue 
10 Acinetobacter 
baumannii NCTC 
12156  ++ 
 ++ yellow 
 ++  ++ blue 
 ++ 
 ++ blue 
        
 Gram-positive 
microorganisms       
11 Streptococcus  -  -  -  - Tr. - 
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pyogenes NCTC 
8306 
12 Staphylococcus 
aureus (MRSA) 
NCTC 11939  - -  - - + ++ blue 
13 Staphylococcus 
aureus  (MSSA) 
NCTC 6571  -  -  -  -  +  ++ blue  
14 Staphylococcus 
epidermidis NCTC 
11047  -  -  -  -  -  - 
15 Listeria 
monocytogenes 
NCTC 11994  -  -  -  -  +  + blue 
16 Enterococcus 
faecium NCTC 
7171  -  -  -  -  + + blue 
17 Enterococcus 
faecalis NCTC 775  - -  - -  + + blue 
18 Bacillus subtilis 
NCTC 9372  -  -  -  -  - - 
        
 Yeasts       
19 Candida albicans 
ATCC 90028 +  ++ blue  +  ++ blue   +  ++ blue 
20 Candida glabrata 
NCPF 3943 -  - -  -  +  ++ blue 
aNCTC: National Collection of Type Cultures; ATCC: American Type Culture Collection; NCPF: National 
Collection of Pathogenic Fungi. 
b ++ strong growth, + moderate growth, +/- weak growth, Tr. trace of growth. 
c ++ strong fluorescence, + moderate fluorescence, +/- weak fluorescence, Tr. trace of fluorescence. 
Table 3. Evaluation of substrates 18d, 18e and 22 
4. Conclusions 
In conclusion, the substrates 18c-18e all produced highly fluorescent colonies with the panel of 
Gram-negative microorganisms. This has been attributed to the combination of two synergistic 
effects; the wide distribution of L-alanylaminopeptidase in Gram-negative microorganisms and the 
inhibitory effect of these substrates against Gram-positive microorganisms. Some Gram-positive 
microorganisms gave fluorescent colonies with substrates that were not inhibitory to their growth 
(substrates 18a and 22).  
 
5. Experimental 
NMR spectra were recorded on a JEOL ECS400 Delta spectrometer at frequencies of 400 MHz for 1H-
NMR spectra and 101 MHz for 13C-NMR spectra. All chemical shifts are quoted in ppm relative to 
TMS as an internal standard. The multiplicity of the signals is expressed as follows; s = singlet, d = 
doublet, dd = doublet of doublets, t = triplet, q = quartet and m = multiplet, or in combinations (e.g. 
td = triplet of doublets). High resolution mass spectra (HRMS) were obtained using a Finnigan MAT 
900 XLT high resolution double focussing mass spectrometer or a Thermo Scientific LTQ Orbitrap XL 
mass spectrometer  using nanoelectrospray ionisation. Low resolution mass spectrometry (LRMS) 
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was performed via direct injection of dilute methanolic solutions (containing 0.1% formic acid) into a 
Thermo Finnigan LCQ Advantage MS detector using electrospray ionisation. Infra-red spectra were 
obtained via a diamond anvil sample cell using a Perkin Elmer 1000FT-IR spectrometer. Melting 
points are reported uncorrected as determined on a Stanford Research Systems MPA161 melting 
point apparatus. Thin layer chromatography was performed on Merck plastic foil plates pre-coated 
with silica gel 60 F254. Merck silica gel 60 was used for column chromatography.   
The preparation of agar plates followed the procedure described previously.10 
5.1 4-Aminobenzyl alcohol (13)11 
A mixture of Cu(acac)2 (0.35 g, 1.31 mmol) and NaBH4 (0.25 g, 6.53 mmol) in EtOH (70 mL) was 
stirred (1 h) under N2. A solution of 4-nitrobenzyl alcohol (1.00 g, 6.53 mmol) in EtOH (70 mL) was 
added followed by NaBH4 (0.50 g, 12.06 mmol). The mixture was stirred (2 h), distilled water (120 mL) 
was added and the mixture was filtered. The filtrate volume was reduced by evaporation of most of 
the EtOH and the remaining solution was extracted with CH2Cl2 (2 x 50 mL). The combined organic 
extracts were dried (MgSO4) and evaporated to yield a brown viscous oil which solidified upon 
standing yielding compound 13 (0.32 g, 40%). This product was used directly without further 
purification. 1H-NMR (400 MHz d6-DMSO) δ 6.91 (2H, d, J = 8.2 Hz, Ar-H), 6.46 (2H, d, J = 8.2 Hz, Ar-H), 
4.88 (2H, bs, NH), 4.75 (1H, t, J = 5.4 Hz, OH), 4.24 (2H, d, J = 5.4 Hz, CH2). 
5.2 6-(1,3-Benzothiazol-2-yl)naphthalen-2-ol (16e) 
A homogeneous mixture of 2-(6-methoxynaphthalen-2-yl)benzothiazole12 (2.0 g, 6.86 mmol) and 
pyridine hydrobromide (20.0 g, 125 mmol) was heated (4 h) at 190 °C < T < 200 °C . The reaction was 
allowed to cool to room temperature and water (30 mL) was added. The mixture was poured into 
warm water (100 mL) and the precipitate was collected. The resulting solid was washed well with 
water and dried in a desiccator giving compound 16e as grey crystals (1.88 g, 99%), mp 251-253°C;  
1H-NMR (400 MHz, d6-DMSO) δ 10.15 (1H, broad s, OH), 8.56 (1H, m, Ar-H), 8.16 (1H, d, J = 7.8 Hz, 
Ar-H), 8.13-7.97 (3H, m, Ar-H), 7.86 (1H, d, J = 8.7 Hz, Ar-H), 7.56 (1H, td, J = 7.8 and 1.0 Hz, Ar-H), 
7.46 (1H, td, J = 7.8 and 1.0 Hz, Ar-H), 7.23-7.16 (2H, m, Ar-H); 13C-NMR (101 MHz, d6-DMSO) δ 168.3 
(Ar-C) , 154.2 (Ar-C), 147.4 (Ar-C), 136.7 (Ar-C), 134.9 (Ar-C), 131.3 (Ar-C), 127.9 (Ar-C), 127.8 (Ar-C), 
127.8 (Ar-C), 127.6 (Ar-C), 127.2 (Ar-C), 125.8 (Ar-C), 124.7 (Ar-C), 123.1 (Ar-C), 122.8 (Ar-C), 120.3 
(Ar-C), 109.4 (Ar-C); IR νmax 3400-3200 (OH), 1635, 1496, 1296, 1260, 1190, 1156, 923, 867, 794, 758, 
721 cm-1; HRMS  calcd for C17H12NOS [M+H]+ 278.0634; found 278.0637. 
5.3 tert-Butyl {(2S)-1-[4-(Hydroxymethyl)anilino]-1-oxopropan-2-yl}carbamate (14) 
Amine 13 (0.74 g, 6.00 mmol) was dissolved in dry THF (40 mL) and the resulting solution was cooled 
to -5 °C in an ice/salt bath. In a separate flask, to a stirred solution of Boc-L-alanine (1.20 g, 6.30 
mmol) in dry THF (40 mL) was added N-methylmorpholine (0.61 g, 6.00 mmol) and the mixture was 
cooled to -5 °C.  Isobutyl chloroformate  (0.82 g, 6.00 mmol) was then added, and after stirring for 90 
seconds at -5 °C, the solution of amine 13 was added drop-wise. The resulting mixture was stirred at 
-5 °C (1 h) and then at room temperature overnight.  The solvent was evaporated and the resulting 
crude product was dissolved in CH2Cl2 and washed successively with 0.1 M aq. citric acid solution, 
10% aq. NaHCO3 solution and water. The organic layer was dried (MgSO4) and evaporated. The 
resulting oil crystallised upon standing giving compound 14 (1.50 g, 85%) as light orange crystals, mp 
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128-129 °C; 1H-NMR (400 MHz, d6-DMSO) δ 9.84 (1H, broad s, NH), 7.50 (2H, d, J = 8.3 Hz, H-2), 7.19 
(2H, d, J = 8.3 Hz, H-3) 7.03 (1H, d, J = 7.3 Hz, NH), 5.07 (1H, t, J = 5.5 Hz, OH), 4.39 (2H, d, J = 5.5 Hz, 
CH2), 4.02-4.10 (1H, m, CH), 1.34 (9H, s, 3 x CH3), 1.21 (3H, d, J = 7.3 Hz, CH3); 13C-NMR (101 MHz, d6-
DMSO) δ 172.2 (C=O), 155.7 (C=O), 138.2 (Ar-C), 137.8 (Ar-C), 127.3 (2 x Ar-C), 119.4 (2 x Ar-C), 78.5 
(C(CH3)3), 63.1 (CH2OH), 50.9 (CHCH3), 28.7 (C(CH3)3), 18.6 (CHCH3); IR νmax 3360 (broad), 3337, 3330, 
2987, 1690 (C=O), 1670 (C=O), 1519, 1316, 1245, 1167, 1001, 834 cm-1; HRMS calcd for C15H23N2O4 
295.1652 [M+H]+; found 295.1656. 
 
5.4 tert-Butyl {(2S)-1-[4-(Chloromethyl)anilino]-1-oxopropan-2-yl}carbamate (15) 
To a stirred solution of compound 14 (1.50 g, 5.10 mmol) in dry CH2Cl2 (20 mL) at 0 °C under N2 was 
added Et3N (1.55 g, 15.30 mmol) followed by the drop-wise addition of methanesulphonyl chloride 
(1.76 g, 15.30 mmol). The reaction mixture was stirred at 0 °C (2 h) and then at room temperature 
(18 h). The solvent was then evaporated and EtOAc (60 mL) was added to the residue.  The solution 
was washed successively with 5% aq. citric acid solution (100 mL), 5% aq. NaHCO3 solution (100 mL) 
and brine (100 mL). The organic layer was dried (MgSO4) and evaporated. The crude product was 
purified by column chromatography (SiO2,  CH2Cl2) giving compound 15 as an off-white powder (1.04 
g, 65%), mp 142-143 °C;  1H-NMR (400 MHz, d6-DMSO) δ  10.03 (1H, broad s, NH), 7.60 (2H, d, J = 8.7 
Hz, H-3), 7.37 (2H, d, J = 8.7 Hz, H-2), 7.11 (1H, d, J = 6.9 Hz, NH), 4.72 (2H, s, CH2), 4.10 (1H, m, CH), 
1.38 (9H, s, 3 x CH3), 1.25 (3H, d, J = 7.3 Hz, CH3); 13C-NMR (101MHz, d6-DMSO) δ 172.6 (C=O), 155.7 
(C=O), 139.7 (Ar-C), 132.8 (Ar-C), 130.0 (2 x Ar-C), 119.7 (2 x Ar-C), 78.6 (C(CH3)3), 51.0 (CHCH3), 46.7 
(CH2Cl),  28.7 (C(CH3)3), 18.5 (CHCH3); IR νmax 3337 (broad, NH), 2986, 1671(C=O), 1514, 1318, 1245, 
1158, 666 cm-1; HRMS calcd for C15H2235ClN2O3 [M+H]+ 313.1313; found 313.1315. 
5.5 (2S)-2-Amino-N-[4-(chloromethyl)phenyl]propanamide Hydrochloride (19) 
Compound 15 (3.00 g) in saturated anhydrous EtOAc/HCl (35 mL) was stirred (1 h) at room 
temperature. The solvent was evaporated giving compound 19 (2.30 g, 91%) as a dark, sticky solid 
which was used without further purification. 1H-NMR (400 MHz, d6-DMSO) δ 11.13 (1H, broad s, NH), 
8.46 (3H, broad s, NH3+), 7.69 (2H, d, J = 8.4 Hz, H-3), 7.42 (2H, d, J = 8.4 Hz, H-4), 4.74 (2H, s, CH2), 
4.18-4.08 (1H, m, CH), 1.49 (3H, d, J = 6.87 Hz, CH3); 13C-NMR (101MHz, d6-DMSO) δ 168.9 (C=O), 
139.0 (Ar-C), 133.5 (Ar-C), 130.1 (2 x Ar-C), 119.9 (2 x Ar-C), 49.4 (CHCH3), 46.6 (CH2Cl), 17.8 (CHCH3); 
IR νmax 3650-2350 (broad, NH3+ and NH), 1681 (C=O stretch), 1607, 1547, 1511, 1416, 1307, 1257, 
1193, 1109, 824 cm-1. 
5.6 tert-Butyl N-[(1S)-1-{[(1S)-1-{[4- 
(Chloromethyl)phenyl]carbamoyl}ethyl]carbamoyl}ethyl]carbamate (20) 
 
A mixture of compound 19 (1.15 g, 5.00 mmol) and N-methylmorpholine (0.56 g, 5.50 mmol) in dry 
DMF (20 mL) was cooled to -5 °C in an ice/salt bath. In a separate flask, to a stirred solution of Boc-L-
alanine (0.99 g, 5.25 mmol), in dry DMF (20 mL) was added N-methylmorpholine (0.51 g, 5.00 mmol) 
and the mixture was cooled to -5 °C.  Isobutyl chloroformate (0.68 g, 5.00 mmol) was added to this 
mixture and after stirring for 90 seconds at -5 °C, the solution of the amine 19 was added. The 
resulting mixture was stirred at -5 °C (1 h) and then at room temperature overnight. The solvent was 
evaporated and the residue was dissolved in EtOAc (60 mL), washed successively with 0.1 M aq. 
citric acid solution (30 mL), 10% aq. NaHCO3 solution (30 mL) and water (30 mL). The organic layer 
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was  dried (MgSO4) and evaporated giving  compound 20 as a light brown powder (1.25 g, 74 %), mp 
164 °C; 1H-NMR (400 MHz, d6-DMSO) δ 10.05 (1H, s, NH), 8.05 (1H, d, J = 7.3 Hz, NH), 7.60 (2H, d, J = 
8.2 Hz, Ar-H), 7.37 (2H, d, J = 8.2 Hz, Ar-H), 7.00 (1H, d, J = 7.3 Hz, NH), 4.72 (2H, s, CH2), 4.39 (1H, dt, 
J = 7.3 Hz, CH), 3.99 (1H, dt, J = 7.3 Hz, CH), 1.38 (9H, s, 3 x CH3), 1.31 (3H, d, J = 6.9 Hz, CH3), 1.18 (3H, 
d, J = 6.9 Hz, CH3);13C-NMR (101 MHz, d6-DMSO) δ 173.1 (C=O), 171.8 (C=O), 155.7 (C=O), 139.5 (Ar-
C), 132.9 (Ar-C), 130.0 (2 x Ar-C), 119.7 (2 x Ar-C), 78.6 (C(CH3)3), 50.2 (CHCH3), 49.5 (CHCH3), 46.7 
(CH2Cl), 28.7 (C(CH3)3), 18.7 (CHCH3), 18.5 (CHCH3); IR νmax  3387 (NH ), 3320 (NH ), 3258 (NH), 2986, 
1689 (C=O ), 1649 (C=O ), 1517, 1292,  1255, 1166, 1023, 679, 656 cm-1; HRMS calcd for 
C18H2735ClN3O4 384.1685 [M+H]+; found 384.1685. 
5.7 tert-Butyl N-[(1S)-1-[(4-{[(4-Methyl-2-oxo-2H- 
chromen-7-yl)oxy]methyl}phenyl)carbamoyl]ethyl]carbamate (17a) 
 
A mixture of 4-methylumbelliferone 16a (0.14 g, 0.80 mmol), compound 15 (0.30 g, 0.80 mmol) and 
Cs2CO3 (0.26 g, 0.80 mmol) was stirred (3 h) in dry DMF (20 mL) at 80 °C. The mixture was allowed to 
cool to room temperature and the solvent was evaporated.  CH2Cl2 (30 mL) was added to the residue. 
The mixture was filtered, the filtrate was washed successively with 10% aq. NaHCO3 solution (30 mL) 
and water (30 mL). The organic fraction was dried (MgSO4) and evaporated giving compound 17a as 
a grey powder (0.33 g, 91%), mp 180-182 °C which was  used without any further purification; 1H-
NMR (400 MHz, d6-DMSO) δ 9.10 (1H, broad s, NH), 7.64 (1H, d, J = 8.7 Hz, Ar-H), 7.58 (2H, d, J = 8.7 
Hz, Ar-H), 7.37 (2H, d, J = 8.7 Hz, Ar-H), 7.08-6.95 (3H, m, 2 x Ar-H, NH), 6.17 (1H, d, J = 0.9 Hz, Ar-H), 
5.11 (2H, s, CH2), 4.07 (1H, m, CH), 2.35 (3H, s, CH3), 1.34 (9H, s, 3 x CH3), 1.21 (3H, d, J = 7.3 Hz, 
CH3);13C-NMR (101 MHz, d6-DMSO) δ 172.5 (C=O), 161.9 (C=O), 160.7 (C=O), 155.7 (Ar-C), 155.2 (Ar-
C), 153.9 (Ar-C), 139.5 (Ar-C), 131.3 (Ar-C), 129.2 (2 x Ar-C), 127.0 (Ar-C), 119.6 (2 x Ar-C), 113.8 (Ar-
C), 113.3 (Ar-C), 111.7 (Ar-C), 102.2 (Ar-C), 78.6 (C(CH3)3), 70.2 (CH2), 51.0 (CHCH3), 28.7 (C(CH3)3), 
18.7 (CH3), 18.5 (CH3); IR νmax 3321 (NH), 3315 (NH), 2980, 1716 (C=O), 1666 (C=O), 1614 (C=O), 1517, 
1385, 1249, 1155, 1069, 842  cm-1; HRMS  calcd for C25H29N2O6 [M+H]+ 453.2020; found 453.2014. 
 
5.8 tert-Butyl N-[(1S)-1-[(4-{[(4-Oxo-2-phenyl-4H- 
chromen-7-yl)oxy]methyl}phenyl)carbamoyl]ethyl]carbamate (17b) 
 
A mixture of 7-hydroxyflavone 16b (0.38 g, 1.60 mmol), compound 15 (0.5 g, 1.60 mmol) and Cs2CO3 
(0.52 g, 1.60 mmol) was stirred (5 h) in dry DMF (20 mL) at 90°C. The mixture was allowed to cool to 
room temperature and the solvent was evaporated. EtOAc (30 mL) was added to the residue and the 
resulting mixture was washed successively with 2.0 M aq. NaOH solution (3 x 30 mL) and water (30 
mL). The organic fraction was dried (MgSO4) and evaporated affording compound 17b as a fluffy 
yellow powder (0.40 g, 49%), mp 113 °C which was not purified further; 1H-NMR (400 MHz, d6-DMSO) 
δ 10.03 (1H, s, NH), 8.10 (2H, dd, J = 7.8 and 1.8 Hz, Ar-H), 7.96 (1H, d, J = 9.2 Hz, Ar-H), 7.67 (2H, d, J 
= 8.7 Hz, Ar-H), 7.62-7.56 (3H, m, Ar-H), 7.48-7.41 (3H, m, Ar-H), 7.15-7.08 (2H, m, Ar-H, NH), 6.99 
(1H, s, Ar-H), 5.22 (2H, s, CH2), 4.13 (1H, dt, J = 7.1 Hz, CH), 1.39 (9H, s, 3 x CH3), 1.27 (3H, d, J = 7.3 Hz, 
CH3); 13C-NMR (101 MHz, d6-DMSO) δ 176.9 (C=O), 172.5 (C=O), 163.5 (C=O), 162.7 (Ar-C), 47.9 (Ar-C), 
155.7 (Ar-C), 139.6 (Ar-C), 132.2 (Ar-C), 131.7 (Ar-C), 131.2 (Ar-C), 129.6 (2 x Ar-C), 129.3 (2 x Ar-C), 
126.7 (3 x Ar-C), 119.6 (2 x Ar-C), 117.8 (Ar-C), 115.7 (Ar-C), 107.4 (Ar-C), 102.4 (Ar-C), 78.6 (C(CH3)3), 
70.4 (CH2O), 51.0 (CHCH3), 28.7 (C(CH3)3), 18.5 (CH3); IR νmax 3350-3260 (broad, NH), 2984, 1681 
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(C=O ), 1628 (C=O), 1600, 1517, 1449, 1366, 1246, 1161, 829, 771 cm-1; LRMS  calcd for C30H30N2O6 
[M+H]+ 537.55; found 536.99. 
5.9 tert-Butyl N-[(1S)-1-({4-[2-(1,3-Benzoxazol-2- 
yl)phenoxymethyl]phenyl}carbamoyl)ethyl]carbamate (17c) 
 
A mixture of 2-(2-hydroxyphenyl)benzoxazole 16c (0.31 g, 1.45 mmol), compound 15 (0.500 g 1.60 
mmol) and Cs2CO3 (0.781 g, 2.40 mmol) were stirred (5 h) in dry DMF (20 mL) at 90oC. The mixture 
was then allowed to cool to room temperature and the solvent was evaporated. EtOAc (40 mL) was 
added to the residue and the resulting mixture was washed successively with saturated aq. NaHCO3 
solution (40 mL) and water (40 mL). The organic fraction was dried (MgSO4) and evaporated. The 
residue was triturated with Et2O and the resulting material was purified by column chromatography 
(SiO2, CH2Cl2 changing to CH2Cl2-MeOH (98:2)) giving compound 17c as a light brown powder (0.19 g, 
26%), mp 101oC; 1H-NMR (400 MHz d6-DMSO) δ 9.92 (1H, s, NH), 8.00 (1H, dd, J = 7.6 Hz, Ar-H), 7.45-
7.59 (5H, m, Ar-H), 7.35-7.41 (2H, m, Ar-H), 7.30 (1H, dd, J = 8.7 Hz, Ar-H), 7.11 (1H, t, J = 7.8 Hz, Ar-
CH), 7.04 (1H, d, J = 6.9 Hz, NH), 5.24 (2H, s, CH2), 4.06 (1H, m, CH), 1.33 (9H, s, 3 x CH3), 1.20 (3H, d, J 
= 7.3 Hz, CH3); 13C-NMR (101 MHz, d6-DMSO) δ 162.0 (C=O), 155.7 (C=O), 150.6 (Ar-C), 141.7 (Ar-C), 
139.1 (Ar-C), 133.7 (Ar-C), 132.0 (Ar-C), 131.6 (Ar-C), 128.1 (Ar-C), 127.5 (Ar-C), 125.8 (2 x Ar-C), 
125.2 (Ar-C), 121.6 (Ar-C), 120.2 (Ar-C), 119.6 (2 x Ar-C), 119.5 (Ar-C), 116.5 (Ar-C), 115.0 (Ar-C), 
111.2 (Ar-C), 78.5 (C(CH3)3), 70.2 (CH2), 50.9(CHCH3), 28.7 (C(CH3)3), 19.3 (CHCH3); IR vmax 3306 (broad, 
NH), 2976, 1669 (C=O), 1602, 1516, 1453, 1414, 1365, 1311, 1245, 1160, 1055, 1018, 822, 749 cm-1; 
HRMS calcd for C28H30N3O5 [M+H]+ 488.2180; found  488.2171. 
 
5.10 tert-Butyl N-[(1S)-1-({4-[2-(1,3-Benzothiazol-2-
yl)phenoxymethyl]phenyl}carbamoyl)ethyl]carbamate (17d) 
A mixture of 2-(2-hydroxyphenyl)benzothiazole 16d (0.33 g, 1.47 mmol), compound 15 (0.46 g, 1.47 
mmol) and Cs2CO3 (0.48 g, 1.47 mmol) was stirred (6 h) in dry DMF (20 mL) at 90 °C. The mixture was 
allowed to cool to room temperature and the solvent was evaporated.  EtOAc (30 mL) was added to 
the residue and the resulting mixture was washed successively with 10% aq. NaHCO3 solution (40 mL) 
and water (40 mL). The organic fraction was dried (MgSO4) and evaporated. The residue was purified 
by column chromatography (SiO2, CH2Cl2 changing to CH2Cl2-MeOH (98:2)) giving compound 17d as a 
white powder (0.27 g, 84%), mp 102 °C; 1H-NMR (400 MHz, d6-DMSO) δ 10.04 (1H, s, NH), 8.46 (1H, 
dd, J = 7.8 and 1.8 Hz, Ar-H), 8.12-8.03 (2H, m, Ar-H), 7.67 (2H, d, J = 8.7 Hz, Ar-H), 7.57-7.50 (4H, m, 
Ar-H), 7.44-7.38 (2H, m, Ar-H), 7.17 (1H, t, J = 7.1 Hz, Ar-H), 7.12 (1H, J = 7.3 Hz, NH), 5.39 (2H, s, CH2), 
4.13 (1H, dt, J = 7.1 Hz, CH), 1.39 (9H, s, 3 x CH3), 1.27 (3H, d, J = 6.9 Hz, CH3);13C-NMR (101 MHz, d6-
DMSO) δ 172.5 (C=O), 162.7 (C=O), 156.4 (Ar-C), 155.7 (Ar-C), 152.0 (Ar-C), 139.6 (Ar-C), 136.0 (Ar-C), 
132.8 (Ar-C), 131.2 (Ar-C), 129.5 (2 x Ar-C), 129.4 (Ar-C), 126.8 (Ar-C), 125.4 (Ar-C), 122.9 (Ar-C), 
122.4 (Ar-C), 122.0 (Ar-C), 121.7 (Ar-C), 119.6 (2 x Ar-C), 114.4 (Ar-C), 78.6 (C(CH3)3), 70.7 (CH2O), 
51.0 (CHCH3), 28.7 (C(CH3)3), 18.5 (CH3); IR νmax 3360-3250 (broad, NH), 2982, 1669 (C=O ), 1601 
(C=O), 1510, 1499, 1244, 1161, 754 cm-1; LRMS calcd for C28H29N3O4SNa [M+Na]+ 526.60; found 
526.13.  
5.11 tert-Butyl N-[(1S)-1-{[4-({[6-(1,3-Benzothiazol-2- 
yl)naphthalen-2-yl]oxy}methyl)phenyl]carbamoyl}ethyl]carbamate (17e) 
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A mixture of 16e (0.30 g, 1.08 mmol), compound 15 (0.41 g, 1.30 mmol) and Cs2CO3 (0.53 g, 1.62 
mmol) was stirred (12 h) in dry DMF (20 mL) at 90 °C. The mixture was allowed to cool to room 
temperature and the solvent was evaporated. EtOAc (60 mL) was added to the residue and the 
mixture was washed successively with 10% aq. NaHCO3 solution (30 mL) and water (2 x 20 mL). The 
organic fraction was dried (MgSO4) and evaporated. The residue was purified by column 
chromatography (eluent; EtOAc, 100%) giving compound 17e as a pink powder (0.40 g, 67%), mp 
204-205 °C; 1H-NMR (400 MHz, d6-DMSO) δ 10.04 (1H, broad s, NH), 8.63 (1H, d, J = 0.9 Hz, NH), 
8.21-8.15 (2H, m, Ar-H), 8.12-8.05 (2H, m, Ar-H), 7.97 (1H, d, J = 8.7 Hz, Ar-H), 7.67 (2H, d, J = 8.7 Hz, 
Ar-H), 7.59-7.53 (2H, m, Ar-H), 7.51-7.43 (3H, m Ar-H), 7.33 (1H, dd, J = 9.2 and 2.3 Hz, Ar-H), 7.11 
(1H, d, J = 7.3 Hz, Ar-H), 5.21 (2H, s, CH2), 4.13 (1H, dt, J = 7.3 Hz, CH), 1.39 (9H, s, 3 x CH3), 1.27 (3H, 
d, J = 7.3 Hz, CH3); 13C-NMR (101 MHz, d6-DMSO) δ 172.5 (C=O), 168.1 (C=O), 158.3 (Ar-C), 155.7 (Ar-
C), 154.2 (Ar-C), 139.5 (Ar-C), 136.3 (Ar-C), 135.0 (Ar-C), 131.7 (Ar-C), 131.1 (Ar-C), 129.2 (2 x Ar-C), 
128.7 (Ar-C), 128.6 (Ar-C), 128.3 (Ar-C), 127.8 (Ar-C), 127.2 (Ar-C), 125.9 (Ar-C), 125.0 (Ar-C), 123.2 
(Ar-C), 122.9 (Ar-C), 120.6 (Ar-C), 119.6 (2 x Ar-C), 108.0 (Ar-C), 78.6 (C(CH3)3), 69.9 (CH2), 51.0 
(CHCH3), 28.7 (C(CH3)3), 18.6 (CH3); IR νmax 3312 (broad, NH), 2980, 1688 (C=O ), 1663 (C=O ), 1603, 
1520, 1248, 1161, 812, 757, 674  cm-1; LRMS calcd for C32H31N3O4SNa [M+Na]+ 576.67; found 576.06. 
5.12 (2S)-2-Amino-N-(4-{[(4-methyl-2-oxo-2H-chromen-7- 
yl)oxy]methyl}phenyl)propanamide Hydrochloride (18a) 
 
Compound 17a (0.26 g, 0.57 mmol) was stirred (2 h) in anhydrous EtOAc/HCl (15 mL) at room 
temperature. The resulting precipitate was collected and dried giving compound 18a (0.20 g, 90%) as 
a white powder, mp 202-204 °C; 1H-NMR (400 MHz, d6-DMSO) δ 10.92 (1H, broad s, NH), 8.35 (3H, 
broad s, NH3+), 7.61-7.68 (3H, m, Ar-H), 7.41 (2H, d, J = 8.7 Hz, Ar-H), 7.02 (1H, d, J = 2.3 Hz, Ar-H), 
6.97 (1H, dd, J  = 8.7 Hz, 2.3 Hz, Ar-H), 6.17 (1H, d, J = 0.9 Hz, Ar-H), 5.13 (2H, s, CH2), 4.01-4.13 (1H, 
m, CH), 2.35 (3H, s, CH3), 1.43 (3H, d, J = 6.9 Hz, CH3);13C-NMR (101 MHz, d6-DMSO) δ 168.9 (C=O), 
161.8 (C=O), 160.7 (Ar-C), 155.2 (Ar-C), 154.0 (Ar-C), 138.8 (Ar-C), 132.2 (Ar-C), 129.3 (2 x Ar-C), 
127.0 (Ar-C), 119.9 (2 x Ar-C), 113.8 (Ar-C), 113.3 (Ar-C), 111.8 (Ar-C), 102.2 (Ar-C), 70.1 (CH2), 18.7 
(CH3), 17.8 (CH3); IR νmax 3600-2550 (broad, NH and NH3+), 1682 (C=O), 1606 (C=O), 1514, 1395, 1260, 
836  cm-1; HRMS calcd for C20H21N2O4  [M]+ 353.1496; found 353.1495. 
5.13 (2S)-2-Amino-N-(4-{[(4-oxo-2-phenyl-4H-chromen-7- 
yl)oxy]methyl}phenyl)propanamide Hydrochloride (18b) 
 
Compound 17b (0.24 g, 0.47 mmol) was stirred (1 h) in anhydrous EtOAc/HCl (10 mL) at room 
temperature. The resulting precipitate was collected and dried giving compound 18b as an orange 
powder (0.20 g, 95%), mp 98-100 °C; 1H-NMR (400 MHz d6-DMSO) δ 11.05 (1H, s, NH), 8.45 (3H, d, J 
= 3.7 Hz, NH3+),  8.10 (2H, dd, J = 7.3 and 1.8 Hz, Ar-H), 7.97 (1H, d, J = 8.7 Hz, Ar-H), 7.75 (2H, d, J = 
8.7 Hz, Ar-H), 7.63-7.56 (3H, m, Ar-H), 7.51 (2H, d, J = 8.7 Hz, Ar-H), 7.44 (1H, d, J = 2.3 Hz, Ar-H), 7.14 
(1H, dd, J = 8.7 and 2.3 Hz, Ar-H), 6.99 (1H, s, Ar-H), 5.25 (2H, s, CH2), 4.17-4.10 (1H, m, CH), 1.50 (3H, 
d, J = 6.9 Hz, CH3);13C-NMR (101 MHz, d6-DMSO) δ 176.9 (C=O), 168.9 (C=O), 163.4 (Ar-C), 162.7 (Ar-
C), 157.9 (Ar-C), 138.9 (Ar-C), 132.2 (Ar-C), 132.0 (Ar-C), 131.7 (Ar-C), 129.63 (2 x Ar-C), 129.3 (2 x Ar-
C), 126.7 (-CH=), 119.9 (2 x Ar-C), 117.8 (Ar-C), 115.7 (Ar-C), 107.3 (Ar-C), 102.5 (Ar-C), 70.3 (CH2), 
49.4 (CHCH3), 17.8 (CH3); IR νmax 3600-2250 (broad, NH3+ NH), 1693 (C=O), 1614 (C=O), 1515, 1450, 
1378, 1246, 1173, 1092, 829, 772, 674  cm-1; HRMS calcd for C25H23N2O4 [M]+ 415.1652; found 
415.1647. 
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5.14 (2S)-2-Amino-N-{4-[2-(1,3-Benzoxazol-2- 
yl)phenoxymethyl]phenyl}propanamide Hydrochloride (18c) 
 
Compound 17c (0.25 g, 0.51 mmol) was stirred (1 h) in anhydrous EtOAc/HCl (5 mL) at room 
temperature. The resulting precipitate was collected and dried giving compound 18c as a light brown 
solid (0.18 g, 83%), mp 132oC, 1H-NMR (400 MHz, d6-DMSO) δ 10.88 (1H, s, NH), 8.36 (3H, bs, NH3+), 
8.00 (1H, dd, J = 7.2 Hz, Ar-H), 7.63-7.78 (4H, m, Ar-H), 7.50-7.56 (3H, m, Ar-H), 7.35-7.41 (2H, m, Ar-
H), 7.30 (1H, dd, J = 8.7 Hz, Ar-H), 7.12 (1H, t, J = 7.3 Hz, Ar-H), 5.25 (2H, s, CH2),  4.04 (1H, m, CH), 
1.42 (3H, d, J = 6.9 Hz, CH3), 13C-NMR (101 MHz, d6-DMSO) δ 155.7 (C=O), 150.6 (Ar-C), 141.7 (Ar-C), 
139.1 (Ar-C), 133.7 (Ar-C), 132.0 (Ar-C), 131.6 (Ar-C), 128.1 (Ar-C), 127.5 (Ar-C), 127.2 (2 x Ar-C), 
125.1 (Ar-C), 121.3 (Ar-C), 121.0 (Ar-C), 119.4 (2 x Ar-C), 119.0 (Ar-C), 116.5 (Ar-C), 115.0 (Ar-C), 
111.1 (Ar-C), 70.2 (CH2), 50.3 (CHCH3), 17.7 (CHCH3); IR vmax 3300-2025 (broad, NH + NH3+), 2976, 
1668 (C=O), 1609, 1515, 1455, 1418, 1310, 1139, 994, 797, 751, 722, 704 cm-1; HRMS  calcd for 
C23H22N3O3 [M]+ 388.1656;  found 388.1653. 
5.15 (2S)-2-Amino-N-{4-[2-(1,3-benzothiazol-2- 
yl)phenoxymethyl]phenyl}propanamide Hydrochloride (18d) 
 
Compound 17d (0.20 g, 0.40 mmol) was stirred (1 h) in anhydrous EtOAc/HCl (10 mL) at room 
temperature. The resulting precipitate was collected and dried giving compound 18d as a yellow 
powder (0.17 g, 97%), mp 136 °C; 1H-NMR (400 MHz, d6-DMSO) δ 11.11 (1H, s, NH), 8.55-8.40 (4H, m, 
Ar-H, NH3+), 8.12-8.03 (2H, m, Ar-H), 7.76 (2H, d, J = 8.7 Hz, Ar-H), 7.62-7.51 (4H, m, Ar-H), 7.45-7.38 
(2H, m, Ar-H), 7.17 (1H, t, J = 7.6 Hz, Ar-H), 5.42 (2H, s, CH2), 4.14 (1H, dt, J = 5.7 Hz, CH), 1.50 (3H, d, 
J = 6.9 Hz, CH3); 13C-NMR (101 MHz, d6-DMSO) δ 168.9 (C=O), 162.7 (Ar-C), 156.4 (Ar-C), 151.9 (Ar-C), 
138.9 (Ar-C), 135.9 (Ar-C), 132.8 (Ar-C), 132.0 (Ar-C), 129.6 (2 x Ar-C), 129.4 (Ar-C), 126.8 (Ar-C), 
125.5 (Ar-C), 122.9 (Ar-C), 122.4 (Ar-C), 122.0 (Ar-C), 121.8 (Ar-C), 119.8 (2 x Ar-C), 114.4 (Ar-C), 70.6 
(CH2), 49.4 (CHCH3), 17.8 (CH3); IR νmax 3650-2250 (broad, NH3+ and NH peaks), 2982, 1666 (C=O ), 
1600 (C=O ), 1515, 1247, 989, 754  cm-1; HRMS calcd for C23H22N3O2S [M]+ 404.1427; found 404.1426.
  
5.16 (2S)-2-Amino-N-[4-({[6-(1,3-benzothiazol-2- 
yl)naphthalen-2-yl]oxy}methyl)phenyl]propanamide Hydrochloride (18e) 
 
Compound 17e (0.25 g, 0.45 mmol) was stirred (1 h) in anhydrous EtOAc/HCl (12 mL) at room 
temperature. The resulting precipitate was collected and dried giving compound 18e as a yellow 
powder (0.13 g, 59%), mp 200-203 °C; 1H-NMR (400 MHz, d6-DMSO) δ 10.30 (1H, broad s, NH), 8.65-
8.55 (1H, m, Ar-H), 8.42-8.28 (3H, m, NH3+), 8.20-7.95 (6H, m, Ar-H), 7.75-7.35 (6H, m, Ar-H), 7.25-
7.18 (1H, m, Ar-H), 5.23 (2H, s, CH2), 4.35-4.25 (1H, m, CH), 1.43 (3H, d, J = 6.9 Hz, CH3); 13C-NMR 
(101 MHz, d6-DMSO) δ 168.1 (C=O), 154.2 (Ar-C), 136.7 (Ar-C), 134.9 (Ar-C), 131.2 (Ar-C), 129.4 (Ar-C), 
129.0 (2 x Ar-C), 128.7 (Ar-C), 128.0 (Ar-C), 127.5 (Ar-C), 127.6 (Ar-C), 127.2 (Ar-C), 125.8 (Ar-C), 
124.7 (Ar-C), 123.1 (Ar-C), 122.9 (Ar-C), 122.8 (Ar-C), 120.3 (Ar-C), 119.9 (2 x Ar-C), 119.8 (Ar-C), 
109.5 (Ar-C), 69.7 (CH2), 49.4 (CHCH3), 17.7 (CH3); IR νmax 3650-2300 (broad, NH3+ and NH), 1690 
(C=O), 1606,1512, 1481, 1254, 1198, 818, 755, 686  cm-1; HRMS calcd for C27H23N3O2S [M]+ 454.1584; 
found 454.1581. 
5.17 tert-Butyl N-[(1S)-1-{[(1S)-1-{[4-({[6-(1,3- 
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Benzothiazol-2-yl)naphthalen-2- 
yl]oxy}methyl)phenyl]carbamoyl}ethyl]carbamoyl}ethyl]carbamate (21) 
 
A mixture of 16e (0.40 g, 1.44 mmol), compound 20 (0.61 g, 1.58 mmol) and Cs2CO3(0.70 g, 2.16 
mmol) was stirred (12 h) in dry DMF (25 mL) at 90 °C. The mixture was allowed to cool to room 
temperature and the solvent was evaporated and water (50 mL) was added to the residue. The 
mixture was extracted with EtOAc (3 x 25 mL) and the organic fractions were dried (MgSO4) and 
evaporated. The residue was purified by column chromatography (SiO2, EtOAc-CH2Cl2 (50:50)) giving 
compound 21 as a yellow powder (0.33 g, 37%), mp 204-205 °C; 1H-NMR (400 MHz, d6-DMSO) δ 
10.05 (1H, s, NH), 9.97 (1H, m, NH), 8.63 (1H, m, NH), 8.21-8.00 (4H, m, Ar-H), 7.97 (1H, d, J = 8.7 Hz, 
Ar-H), 7.66 (1H, d, J = 8.7 Hz, Ar-H), 7.60-7.42 (5H, m, Ar-H), 7.33 (1H, dd, J = 8.7 and 2.3 Hz, Ar-H), 
7.25 (1H, d, J = 8.5 Hz, Ar-H), 7.01 (1H, d, J = 7.3 Hz, Ar-H), 5.21 (2H, s, CH2), 4.45-4.38 (1H, m, CH), 
4.04-3.96 (1H, m, CH), 1.38-1.31 (12H, m, CH3, 3 x CH3), 1.20 (3H, d, J = 7.3 Hz, CH3); 13C-NMR (101 
MHz, d6-DMSO) δ 173.1 (C=O), 171.8 (C=O), 168.8 (C=O), 158.3 (Ar-C), 155.7 (Ar-C), 154.2 (Ar-C), 
139.3 (Ar-C), 136.3 (Ar-C), 135.0 (Ar-C), 131.9 (Ar-C), 131.1 (Ar-C), 129.2 (Ar-C), 128.7 (2 x Ar-C), 
128.3 (Ar-C), 127.7 (Ar-C), 127.2 (Ar-C), 125.9 (Ar-C), 125.0 (Ar-C), 123.2 (Ar-C), 122.9 (Ar-C), 120.6 
(Ar-C), 119.7 (2 x Ar-C), 119.5 (Ar-C), 108.0 (Ar-C), 78.6 (C(CH3)3), 69.8 (CH2), 50.2 (CHCH3), 49.4 
(CHCH3), 28.7 (C(CH3)3), 18.8 (CHCH3), 18.5 (CHCH3); IR νmax 3340-3240 (broad, NH), 2980, 1690 (C=O), 
1655 (C=O), 1645 (C=O), 1514, 1249, 1163, 1019, 802, 756  cm-1;  HRMS calcd for C35H37N4O5S [M+H]+ 
625.2479; found 625.2474. 
5.18 (2S)-2-[(2S)-2-Aminopropanamido]-N-[4-({[6-(1,3- 
benzothiazol-2-yl)naphthalen-2-yl]oxy}methyl)phenyl]propanamide Hydrochloride (22) 
 
Compound 21 (0.20 g, 0.32 mmol) was stirred (1 h) in anhydrous EtOAc/HCl (10 mL) at room 
temperature. The resulting precipitate was collected and dried giving compound 22 (0.10 g, 56%) as 
an orange powder, mp > 220 °C; 1H-NMR (400 MHz, d6-DMSO) δ 10.03 (1H, s, NH), 8.80-8.57 (1H, m, 
NH), 8.28-7.85 (10H, m, NH3+, Ar-H), 7.68 (1H, d, J = 8.7 Hz, Ar-H), 7.57-7.31 (5H, m, Ar-H), 7.17 (1H, d, 
J = 8.7 Hz, Ar-H), 5.22 (2H, s, CH2), 4.54-4.42 (1H, m, CH), 3.94-3.81 (1H, m, CH), 1.45-1.27 (6H, m, 2 x 
CH3); IR νmax 3650-2400 (broad, NH3+ and NH), 1667 (C=O), 1601, 1514, 1446, 1393, 1249, 1179, 818, 
757  cm-1; HRMS calcd for C30H29N4O3S [M]+ 525.1955; found 525.1943. 
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